Research ExplorerJournalsNAT REV DRUG DISCOV Publications

NAT REV DRUG DISCOV

1 - 5 out of 5Page size: 50

Publications

  1. 2020

  2. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

    Sebestyen, Z., Prinz, I., Déchanet-Merville, J., Silva-Santos, B. & Kuball, J., 03.2020, In: NAT REV DRUG DISCOV. 19, 3, p. 169-184 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  3. 2016

  4. Altering the course of schizophrenia: progress and perspectives

    Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., Kahn, R., Krebs, M-O., Leboyer, M., Lewis, D., Marin, O., Marin, P., Meyer-Lindenberg, A., McGorry, P., McGuire, P., Owen, M. J., Patterson, P., Sawa, A., Spedding, M., Uhlhaas, P., Vaccarino, F., Wahlestedt, C. & Weinberger, D., 07.2016, In: NAT REV DRUG DISCOV. 15, 7, p. 485-515 31 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2013

  6. The placebo response in medicine: minimize, maximize or personalize?

    Enck, P., Bingel, U., Schedlowski, M. & Rief, W., 01.03.2013, In: NAT REV DRUG DISCOV. 12, 3, p. 191-204 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2009

  8. Capturing adenylyl cyclases as potential drug targets.

    Pierre, S., Eschenhagen, T., Geisslinger, G. & Scholich, K., 2009, In: NAT REV DRUG DISCOV. 8, 4, p. 321-335 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2003

  10. Tissue microarrays in drug discovery.

    Sauter, G., Simon, R. & Hillan, K., 2003, In: NAT REV DRUG DISCOV. 2, 12, p. 962-972 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review